The Blue Eye Clinic is one of the few centers to use the new nanosecond laser for maculopathy.
Also known as 2RT (or Retinal Rejuvenation Therapy), the laser uses pulses lasting only 3 nanoseconds and enormously lower energy than traditional retinal lasers.
Thanks to this exclusive feature, the action of the 2RT laser is photostimulating. It induces biological reparative processes on the treated retina, resulting in structural and functional improvement without the photocoagulant side effects of traditional lasers.
The pathogenetic processes at the very basis of maculopathy are thus counteracted to stop or slow down the progression of visual damage.
The 2RT laser is currently the only laser subjected to a rigorous multicentre clinical trial for treating the dry form of maculopathy, characterized by the presence of drusen, and for which there are currently no proven effective treatments.
Thanks to the 2RT laser, it is now possible to intervene from the early stages of the disease to maintain good visual function for as long as possible.
The 2RT nanosecond laser is also indicated for the treatment of diabetic macular edema. It can also be useful in treating other forms of maculopathy, such as central serous chorioretinopathy.
The operation, which is absolutely non-invasive and completely painless, is performed on an outpatient basis and lasts a few minutes, with minimal discomfort for the patient, who can then be discharged immediately after the procedure.
However, an accurate preliminary clinical and instrumental evaluation of the individual patient is performed before the surgery.
The surgery does not cause any risk of infection or inflammation, has no contraindications with other treatments or concomitant drug therapies, and can be repeated, if necessary, after 6 or 12 months.